Gilead Sciences, Inc. is a company in the U.S. stock market and it is a holding in 301 U.S.-traded ETFs. GILD has around 150.8M shares in the U.S. ETF market. The largest ETF holder of GILD is the Invesco QQQ Trust (QQQ), with approximately 17.84M shares. Investors may also find of interest that the ETF with the largest allocation to GILD stock is First Trust Nasdaq Pharmaceuticals ETF (FTXH), with a portfolio weight of 8.18%. On average, U.S. ETFs allocate 0.92% of GILD to their portfolios.
Additionally, GILD is a favorite stock for Multi-factor and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with GILD as a holding is the ProShares Ultra QQQ (QLD), with a return of 193.00%.